Why study sympathetic nervous system?

Journal of Physiology and Pharmacology

Volumn 57, Issue SUPPL. 11, 2006, Pages 79-92

  Sinski, M ^a   Lewandowski, J ^a   Abramczyk, P ^a   Narkiewicz, K ^b   Gaciong, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

BRS; HRV; Microneurography; Noradrenaline; Sympathetic nervous system

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; NEUROHORMONE; NORADRENALIN;

ADRENALIN URINE LEVEL; ADRENERGIC SYSTEM; ALPHA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE MONITORING; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATECHOLAMINE BLOOD LEVEL; CLINICAL PRACTICE; CLINICAL RESEARCH; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIABETIC NEUROPATHY; ESSENTIAL HYPERTENSION; HEART ARRHYTHMIA; HEART FAILURE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; METABOLIC DISORDER; NORADRENALIN BLOOD LEVEL; NORADRENALIN URINE LEVEL; PATHOGENESIS; PRESSORECEPTOR; PRESSORECEPTOR REFLEX; SUDDEN DEATH; SYMPATHETIC TONE;

BAROREFLEX; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIABETIC NEUROPATHIES; HEART FAILURE; HEART RATE; HUMANS; HYPERTENSION; NOREPINEPHRINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 34147131181     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Mark AL. The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens 1996; 14(suppl 5): 159-165.
2. Mancia G. Bjorn Folkow Award Lecture: the sympathetic nervous system in hypertension. J Hypertens 1997; 15: 1553-1565.
3. Julius S, Nesbitt S. Sympathetic overactivity in hypertension. A moving target. Am J Hypertens 1996; 9: 113-120.
4. Esler M, Lambert G, Brunner-La Rocca HP, Vaddadi G, Kaye D. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand 2003; 177: 275-284.
5. Narkiewicz K. Sympathetic nervous system and hypertension. Via Medica Press, Gdansk 2001.
6. Goldstein DS. Plasma catecholamines and essential hypertension: an analytical review. Hypertension 1983; 5: 86-99.
7. Esler MD, Lambert G, Jennings G. Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens 1989; 11 (suppl 1): 75-89.
8. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 1988; 14: 1277-1283.
9. Floras JS, Hara K. Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension. J Hypertens 1993; 11: 647-655.
10. Grassi G, Dell'Oro R, Bertinieri G, Turri C, Stella ML, Mancia G. Sympathetic nerve traffic and baroreflex control of circulation in systodiastolic and isolated systolic hypertension of the elderly. J Hypertens 1999; 17 (suppl 3): 45-46.
11. Peterson HR, Rothschild M, Weinberg CR, et al. Body fat and the activity of the autonomic nervous system. N Engl J Med 1988; 318: 1077-1083.
12. Young JB, MacDonald IA. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes Relat Metab Disord 1992; 16: 959-967.
13. Julius S.Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 1993; 21: 886-893.
14. Gottlieb SS, McCarter RJ, Vogel RA. Effect of ß-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Eng J Med 1998; 339: 489-97.
15. Graham LN, Smith PA, Stoker JB, Mackintosh AF, Mary DA. Sympathetic neural hyperactivity and its normalization following unstable angina and acute myocardial infarction. Clin Sci 2004; 106: 605-611.
16. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986; 73: 615-621.
17. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients, with chronic congestive heart failure. N Engl J Med 1984; 311: 819-823.
18. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995; 26: 1257-1263.
19. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens 1999; 7: 719-734.
20. Grassi G, Bolla GB, Seravalle G, Turri C, Lanfranchi A, Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci 1997; 92: 285-289.
21. Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987: 80: 812-817.
22. Esler M, Jennings G, Korner P, et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988; 11: 3-20.
23. Esler M, Jennings G, Lambert G. Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens 1989; 2: 140-146.
24. Ferrier C, Essler MD, Eisenhofer G, et al. Increased norepinephrine spillover into the jugular veins in essential hypertension. Hypertension 1992; 19: 62-69.
25. Essler MD, Lambert GW, Ferrier C, et al. Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. Clin Exp Hypertens 1995; 17: 409-423.
26. Rumantir MS, Kaye DM, Jennings GL, Vaz M, Hastings JA, Esler MD. Phenotypic evidence of faulty neuronal noradrenaline reuptake in essential hypertension. Hypertension 2000; 36: 824-829.
27. Schlaich MP, Lambert E, Kaye DM, et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 2004; 43: 169-175.
28. Eisenhofer G, Friberg P, Rundqvist B. et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996; 93: 1667-1676.
29. Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J 2003; 22: 1136-1143.
30. Wallin G. Intraneural recording and autonomic function in man. In Autonomic Failure R. Banister (ed.) London, UK: Oxford University Press 1983: pp. 36-51.
31. Mark AL, Victor RG, Nerhed G, Wallin BG: Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res 1985; 57: 461-469.
32. Macefield VG, Wallin BG, Vallbo AB. The discharge behaviour of single vasoconstrictor motor neurones in human muscle nerves. J Physiol (Lond) 1994; 481: 799-809.
33. Huggett RJ, Scott EM, Gilbey SG, Stoker JB, Mackintosh AF, Mary DA. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 2003; 108: 3097-3101.
34. Hagbarth KE, Hallin RG, Hongell A, Torebjork HE, Wallin BG. General characteristics of sympathetic activity in human skin nerves. Acta Physiol Scand 1972; 84: 164-172.
35. van de Borne P, Montano M, Pagani N, Zimmerman B, Somers VK. Relationship between repeated measures of hemodynamics, muscle sympathetic nerve activity and their spectral oscillations. Circulation 1997; 96: 4326-4332.
36. Wallin BG, Victor RG, Mark AL. Sympathetic outflow to resting muscles in arm and leg during isometric handgrip and post-handgrip muscle ischemia. Am J Physiol 1989; 256: 105-110.
37. Somers VK, Mark AL, Abboud FM. Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects. Hypertension 1988; 11: 608-612.
38. Narkiewicz K, van de Borne PJH, Pesek CA, Dyken ME, Montano N, Somers VK. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 1999; 99: 1183-1189.
39. Narkiewicz K, Pesek CA, van de Borne PJH, Kato M, Somers VK. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 1999; 100: 262-267.
40. Malik M, Bigger JT, Camm AJ, et al. Task Force of the European Society of Cardiology an the North American Society of Pacing and Electrophysiology - Heart Rate Variability: Standard of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-1065.
41. Makikallio TH, Tapanainen JM, Tulppo MP, et al. Clinical applicability of heart rate variability analysis by methods based on nonlinear dynamics. Card Electrophysiol Rev 2002; 6: 250-255.
42. Tsuji H, Venditti FJ, Manders ES, et al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham heart study. Circulation 1994; 90: 878-883.
43. La Rovera MT, Pinna GD, Maestri R, et al. Short term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003; 107: 565-570.
44. Priori SG, Aliot E, Blomstron-Lundqvist C, et al. Task Force on Sudden Cardiac Death of European Society of Cardiology. Eur Heart J 2001; 22: 16.
45. Dekker JM, Crow RS, Folsom AR, et al. Low Heart Rate Variability in a 2-Minute Rhythm Strip Predicts Risk of Coronary Heart Disease and Mortality From Several Causes : The ARIC Study. Circulation 2000; 102: 1239-1244.
46. Diabetic Neuropathies: A Statement by the ADA Diabetes Care. 2005; 28 (4): 956-962.
47. Eckberg DL, Cavanaugh MS, Mark AL, Abboud FM. A simplified neck suction device for activation of carotid baroreceptors. J Lab Clin Med 1975; 85: 167-173.
48. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity. Circ Res 1969; 24: 109-121.
49. Robbe HW, Mulder LJ, Ruddel H, et al. Assessment of baroreceptor reflex sensitivity by means of spectral analysis Hypertension 1987; 10; 538-543.
50. Barron H V and Lesh MD Autonomic nervous system and sudden cardiac death. J Am Coll Cardiol 1996; 27: 1053-1060.
51. Hartikainen JEK, Camm AJ. Baroreflex sensitivity in patients with myocardial infarction. Edit Cardiol 1995; 1: 72- 80.
52. Thames MD, Kinugawa T, Smith ML, Dibner Dunlap ME. Abnormalities of baroreflex control in heart failure. J Am Coll Cardiol 1993; 22: 56-60.
53. LaRovere MT, Bigger Jr JT, Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction). Lancet 1998; 351: 478-484.
54. La Rovere MT, Pinna GD, Hohnloser SH, et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001; 103: 2072- 2077.
55. Mortara A, LaRovere MT, Pinna GD, et al. Arterial baroreflex modulation of heart rate in chronic heart failure, clinical and hemodynamic correlates and prognostic implications. Circulation 1997; 96: 3450-3458.